다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Rigel Pharmaceuticals Inc (RIGL)
Rigel Pharmaceuticals Inc (RIGL) 뉴스

RIGL

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RIGL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/04/30	21:05	PR Newswire (US)	Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/04/11	05:30	PR Newswire (US)	Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/04/04	21:05	PR Newswire (US)	Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/03/12	21:05	PR Newswire (US)	Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/03/06	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/03/06	06:06	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/03/06	06:01	PR Newswire (US)	Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/03/02	09:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/03/02	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/03/02	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/03/02	09:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/02/27	22:05	PR Newswire (US)	Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/02/22	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/02/22	21:50	PR Newswire (US)	Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/02/15	04:30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/02/07	10:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/02/07	10:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/02/07	10:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/02/02	23:56	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/26	11:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/26	11:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/26	11:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/26	11:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/26	03:48	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/08	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/08	22:05	PR Newswire (US)	Rigel Pharmaceuticals Provides Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/06	06:30	PR Newswire (US)	Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/04	22:05	PR Newswire (US)	Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/01/03	22:05	PR Newswire (US)	Rigel to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2023/12/08	22:05	PR Newswire (US)	Rigel Pharmaceuticals and MD Anderson Announce Strategic Alliance to Advance REZLIDHIA® (Olutasidenib) in AML and Other Cancers	NASDAQ:RIGL	Rigel Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:RIGL

1 2 3 4 5 6 7 8 9 10 다음 >>

BNP Paribas (QX)

Gold vs US Dollar

Invesco QQQ Trust Series 1

US Dollar vs Yen

Financial Select Sector

Verizon Communications

Deutsche Telekom (QX)

JP Morgan Chase

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관